首页 | 本学科首页   官方微博 | 高级检索  
检索        

替吉奥治疗老年进展期胃癌的临床观察
引用本文:邱国钦,许丽贞,林智才,陈玉强.替吉奥治疗老年进展期胃癌的临床观察[J].中国肿瘤临床与康复,2011(1):61-63.
作者姓名:邱国钦  许丽贞  林智才  陈玉强
作者单位:解放军第一七四医院肿瘤中心;
摘    要:目的观察替吉奥一线治疗老年进展期胃癌的近期有效性及安全性。方法 56例老年进展期胃癌患者随机分为两组:治疗组28例口服替吉奥胶囊40 mg/m2,Bid,d1~28,q5w;对照组28例口服卡培他滨片1250 mg/m2,Bid,d1~14,q3w;化疗3个周期后评价近期疗效及不良反应。结果 56例均可评价;治疗组和对照组的近期有效率(RR)分别为46.4%和42.9%,两组比较差异无显著性(P>0.05),但治疗组的不良反应及严重反应发生率均明显低于对照组(P<0.01)。结论替吉奥治疗老年进展期胃癌的疗效较好,不良反应轻,值得临床进一步研究应用。

关 键 词:胃肿瘤/化学治疗  老年  替吉奥  卡培他滨

Clinical observation of S-1 in the treatment of old patients with advanced gastric carcinoma
QIU Guo-qin,XU Li-zhen,LIN Zhi-cai,et al.Clinical observation of S-1 in the treatment of old patients with advanced gastric carcinoma[J].Chinese Journal of Clinical Oncology and Rehabilitation,2011(1):61-63.
Authors:QIU Guo-qin  XU Li-zhen  LIN Zhi-cai  
Institution:QIU Guo-qin,XU Li-zhen,LIN Zhi-cai,et al(Departmet of Oncology,The 174 Hospital of People′s Liberation Army,Xiamen Fujian 361003,China)
Abstract:Objective To examine the short-term efficacy and safety of S-1 in the treatment of old patients with advanced gastric carcinoma.Methods Fifty-six old patients with advanced gastric carcinoma were randomly divided into two groups.S-1(40 mg/m2)was taken by mouth in the experimental group,bid,d1-28,q5w;Capecitabine(1250 mg/m2)was taken by mouth in the control group,bid,d1-14,q3w.Short-term efficacy and adverse reactions were evaluated after three treatment cycles.Results The response rates(RR)of the experiment...
Keywords:Gastric neoplasms/chemotherapy  Old patients  S-1  Capecitabine  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号